biotin has been researched along with fumagillin in 1 studies
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (fumagillin) | Trials (fumagillin) | Recent Studies (post-2010) (fumagillin) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 326 | 5 | 68 |
| Protein | Taxonomy | biotin (IC50) | fumagillin (IC50) |
|---|---|---|---|
| Methionine aminopeptidase 2 | Homo sapiens (human) | 0.0082 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biemann, K; Chang, YH; Chen, S; Griffith, EC; Liu, JO; Su, Z; Turk, BE; Wu, Z | 1 |
1 other study(ies) available for biotin and fumagillin
| Article | Year |
|---|---|
Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
Topics: Affinity Labels; Amino Acid Sequence; Aminopeptidases; Animals; Antibiotics, Antineoplastic; Biotin; Cattle; Cells, Cultured; Cyclohexanes; Endothelium, Vascular; Eukaryotic Initiation Factor-2; Fatty Acids, Unsaturated; Metalloendopeptidases; Mice; Molecular Sequence Data; Molecular Structure; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Phosphorylation; Recombinant Proteins; Sesquiterpenes; Yeasts | 1997 |